Heidelberg Pharm
Stock
Stock
ISIN: DE000A11QVV0
Ticker: HPHA
DE000A11QVV0
HPHA
Price
Price
CHART BY
Frequently asked questions
What is Heidelberg Pharm's market capitalization?
The market capitalization of Heidelberg Pharm is $134.24M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Heidelberg Pharm?
Heidelberg Pharm's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.812. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Heidelberg Pharm's stock?
Currently, 1 analysts cover Heidelberg Pharm's stock, with a consensus target price of $9.182. Analyst ratings provide insights into the stock's expected performance.
What is Heidelberg Pharm's revenue over the trailing twelve months?
Over the trailing twelve months, Heidelberg Pharm reported a revenue of $8.54M.
What is the EBITDA for Heidelberg Pharm?
Heidelberg Pharm's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$36.25M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Heidelberg Pharm?
Heidelberg Pharm has a free cash flow of -$28.54M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Heidelberg Pharm have, and what sector and industry does it belong to?
Heidelberg Pharm employs approximately 120 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Heidelberg Pharm's shares?
The free float of Heidelberg Pharm is 9.82M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $134.24M
- EPS (TTM)
- -$0.812
- Free Float
- 9.82M
- Revenue (TTM)
- $8.54M
- EBITDA (TTM)
- -$36.25M
- Free Cashflow (TTM)
- -$28.54M
Pricing
- 1D span
- $2.703$2.94
- 52W span
- $2.716$4.266
Analyst Ratings
The price target is $9.182 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Heidelberg Pharma AG is a biopharmaceutical company, which engages in the research and development of drugs for cancer patients. The firm focuses on oncology; and development Amanitin, a toxin used in cancer therapies. It also offers tumor implantation models, inflammatory and autoimmune diseases, and bioanalytics services. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth, and Thomas Luther in September 1997 and is headquartered in Ladenburg, Germany.
- Employees
- 120
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- DE000A11QVV0
- Primary Ticker
- HPHA
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet